U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07650110) titled 'Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2' on June 10.
Brief Summary: CERVCO is the French National Reference Centre for Rare Cerebrovascular and Retinal Diseases, accredited by the Ministry of Health since 2005. Since 2017, CERVCO has coordinated the MRVC cohort, a prospective cohort of patients with rare vascular diseases of the brain and retina, and established the associated B-MRVC biobank in 2020 to support translational research and biomarker discovery.
Due to the rarity and heterogeneity of these disorders, centralized longitudinal collection of clinical data and biological samples is...